VALN logo

Valneva SE (VALN)

Profile

Full Name

Valneva SE

Ticker Symbol

VALN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

May 5, 2021

Indexes

Not included

Website

http://valneva.com

Employees

713

Key Details

Price

$6.83(-3.12%)

Market cap

$554.59M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$183.54M(+10.30% YoY)

Annual EPS

-$0.17(+89.04% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.83
VALN price is $6.83

30-Day Relative Volume

1.02
VALN 30-day relative volume is 1.02

Price Performance

Price Today change

-3.12%
VALN price is down -3.12% today

Price YTD change

+56.22%
VALN price is up +56.22% since January 1st

Price 1-year change

-14.62%
VALN price is down -14.62% year-on-year

Price 3-year change

-81.82%
VALN price is down -81.82% over the past 3 years

Price Range

Price All-time high

$67.84
VALN price is currently -89.93% below its historical high of $67.84

Price 3-year low

$3.62
VALN price is currently +88.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$554.59M
VALN market capitalization is $554.59 million

Market cap 3-year change

-72.61%
VALN market capitalization is down -72.61% over the past 3 years

Market cap All-time high

$3.53B
VALN market capitalization is currently -84.29% below its historical high of $3.53 billion

Market cap sector rank

70.64%
VALN market capitalization is higher than 70.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16.7%
VALN shares outstanding is up +16.7% year-on-year

Shares Outstanding 3-Year Change

+50.64%
VALN shares outstanding is up +50.64% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.96
VALN beta is 0.96

200-day SMA

$6.13
VALN price is currently +11.37% above its 200-day simple moving average

50-day SMA

$6.99
VALN price is currently -2.27% below its 50-day simple moving average

RSI

53.95
VALN 14-day relative strength index is 53.95

Volume

1.02
VALN 30-day relative volume is 1.02

ATR

$0.51
VALN average true range is $0.51

10-day Historical Volatility

126.45%
VALN 10-day historical volatility is 126.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$183.54M
VALN annual revenue is $183.54 million

Revenue Analysts estimate

$193.12M
VALN annual revenue is currently -4.96% lower than the consensus analysts' forecast

Revenue 1-year change

+10.3%
VALN annual revenue is up +10.3% year-on-year

Revenue Sector rank

62.79%
VALN annual revenue is higher than 62.79% of companies in Healthcare sector

EPS

EPS

-$0.17
VALN annual earnings per share is -$0.17

EPS Analysts estimate

-$0.73
VALN annual earnings per share is currently -76.32% lower than the consensus analysts' forecast

EPS 1-year change

+89.04%
VALN annual earnings per share is up +89.04% year-on-year

EPS Sector rank

78.21%
VALN annual earnings per share is higher than 78.21% of companies in Healthcare sector

Profit

Gross profit

$76.89M
VALN annual gross profit is $76.89 million

Gross margin

41.89%
VALN annual gross profit margin is 41.89%

Operating profit

-$84.17M
VALN annual operating income is -$84.17 million

Operating margin

-45.86%
VALN annual operating profit margin is -45.86%

Net income

-$13.26M
VALN annual net profit is -$13.26 million

Net margin

-7.22%
VALN annual net profit margin is -7.22%

Expenses

Total expenses

$267.72M
VALN annual total expenses is $267.72 million

Operating expenses

$161.06M
VALN annual total operating expenses is $161.06 million

Cost of goods sold

$106.65M
VALN annual cost of goods sold is $106.65 million

Selling, general & administrative expenses

$102.94M
VALN annual SGA is $102.94 million

Depreciation and amortization

$21.20M
VALN annual depreciation & amortization is $21.20 million

Interest expense

$25.96M
VALN annual interest expense is $25.96 million

Income tax

$823.70K
VALN annual income tax is $823.70 thousand

EBIT & EBITDA

EBIT

$13.53M
VALN annual earnings before interest & taxes is $13.53 million

EBITDA

$34.73M
VALN annual EBITDA is $34.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$520.32M
VALN annual total assets is $520.32 million

Non current assets

$209.18M
VALN annual long term assets is $209.18 million

Current assets

$311.14M
VALN annual total current assets is $311.14 million

Cash and cash equivalents

$175.10M
VALN annual cash & cash equivalents is $175.10 million

Accounts receivable

$36.63M
VALN annual accounts receivable is $36.63 million

Inventory

$55.84M
VALN annual inventory is $55.84 million

Liabilities

Total liabilities

$331.71M
VALN annual total liabilities is $331.71 million

Long term liabilities

$212.49M
VALN annual total long term liabilities is $212.49 million

Current liabilities

$119.23M
VALN annual total current liabilities is $119.23 million

Accounts payable

$13.15M
VALN annual accounts payable is $13.15 million

Debt

Total debt

$225.09M
VALN annual total debt is $225.09 million

Total debt 1-year change

-2.49%
VALN annual total debt is down -2.49% year-on-year

Long term debt

$200.78M
VALN annual long term debt is $200.78 million

Short term debt

$24.31M
VALN annual short term debt is $24.31 million

Equity & Capital

Shareholders equity

$188.61M
VALN annual stockholders equity is $188.61 million

Book value

$188.61M
VALN annual book value is $188.61 million

Retained earnings

-$586.81M
VALN annual retained earnings is -$586.81 million

Working capital

$191.92M
VALN annual working capital is $191.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$72.75M
VALN annual cash flow from operations is -$72.75 million

Cash from operations 1-year change

+66.85%
VALN annual cash flow from operations is up +66.85% year-on-year

Cash from investing

$83.25M
VALN annual cash flow from investing activities is $83.25 million

Cash from investing 1-year change

+473.56%
VALN annual cash flow from investing activities is up +473.56% year-on-year

Cash from financing

$33.21M
VALN annual cash flow from financing activities is $33.21 million

Cash from financing 1-year change

-51.37%
VALN annual cash flow from financing activities is down -51.37% year-on-year

CAPEX

CAPEX

$17.80M
VALN annual capital expenditures is $17.80 million

CAPEX 1-year change

+14.87%
VALN annual capital expenditures is up +14.87% year-on-year

Free Cash Flow

Free cash flow

-$90.55M
VALN annual free cash flow is -$90.55 million

Free cash flow 1-year change

+61.47%
VALN annual free cash flow is up +61.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

41.89%
VALN annual gross profit margin is 41.89%

Operating margin

-45.86%
VALN annual operating profit margin is -45.86%

Net margin

-7.22%
VALN annual net profit margin is -7.22%

ROA & ROE

ROA

-2.58%
VALN annual return on assets is -2.58%

ROE

-8.02%
VALN annual return on equity is -8.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VALN price to earnings ratio value is unknown

PE ratio Sector rank

-
VALN price to earnings ratio is unknown

PB Ratio

PB ratio

2.94
VALN price to book ratio is 2.94

PB ratio Sector rank

72.1%
VALN price to book ratio is higher than 72.1% of companies in Healthcare sector

PS Ratio

PS ratio

3.02
VALN price to sales ratio is 3.02

PS ratio Sector rank

52.31%
VALN price to sales ratio is higher than 52.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$604.58M
VALN enterprise value is $604.58 million

Enterprise value Sector rank

70.97%
VALN enterprise value is higher than 70.97% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

42.59
VALN EV/EBITDA is 42.59

EV/EBITDA Sector rank

96.61%
VALN EV/EBITDA is higher than 96.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.61
VALN annual current ratio is 2.61

Quick ratio

2.14
VALN annual quick ratio is 2.14

Leverage

Debt to equity

1.03
VALN annual debt to equity ratio is 1.03

Interest coverage ratio

0.52
VALN annual interest coverage ratio is 0.52

Risk & Stability

Piotroski F-Score

3
VALN piotroski f-score is 3

Altman Z-Score

0.31
VALN altman z-score is 0.31

Analyst ratings

Recent major analysts updates

Apr 9, 25 HC Wainwright & Co.
Buy
Apr 2, 25 HC Wainwright & Co.
Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Mar 24, 25 HC Wainwright & Co.
Buy
Mar 24, 25 Guggenheim
Buy
Mar 21, 25 HC Wainwright & Co.
Buy
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 19, 25 HC Wainwright & Co.
Buy
Feb 5, 25 HC Wainwright & Co.
Buy
Jan 31, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ACCD logo
Accolade (ACCD)
PHAR logo
Pharming Group NV (PHAR)
GHRS logo
GH Research (GHRS)
FLGT logo
Fulgent Genetics (FLGT)
ANAB logo
AnaptysBio (ANAB)
COGT logo
Cogent Biosciences (COGT)
SIBN logo
SI-BONE (SIBN)
AVNS logo
Avanos Medical (AVNS)
RXST logo
RxSight (RXST)
  • What is the ticker symbol for Valneva SE?
  • Does Valneva SE pay dividends?
  • What sector is Valneva SE in?
  • What industry is Valneva SE in?
  • What country is Valneva SE based in?
  • When did Valneva SE go public?
  • Is Valneva SE in the S&P 500?
  • Is Valneva SE in the NASDAQ 100?
  • Is Valneva SE in the Dow Jones?
  • When was Valneva SE's last earnings report?
  • When does Valneva SE report earnings?

What is the ticker symbol for Valneva SE?

The ticker symbol for Valneva SE is NASDAQ:VALN

Does Valneva SE pay dividends?

No, Valneva SE does not pay dividends

What sector is Valneva SE in?

Valneva SE is in the Healthcare sector

What industry is Valneva SE in?

Valneva SE is in the Biotechnology industry

What country is Valneva SE based in?

Valneva SE is headquartered in France

When did Valneva SE go public?

Valneva SE's initial public offering (IPO) was on May 5, 2021

Is Valneva SE in the S&P 500?

No, Valneva SE is not included in the S&P 500 index

Is Valneva SE in the NASDAQ 100?

No, Valneva SE is not included in the NASDAQ 100 index

Is Valneva SE in the Dow Jones?

No, Valneva SE is not included in the Dow Jones index

When was Valneva SE's last earnings report?

Valneva SE's most recent earnings report was on Mar 20, 2025

When does Valneva SE report earnings?

The next expected earnings date for Valneva SE is May 7, 2025
On this page